Crow Point Partners’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-260
| Closed | -$29K | – | 150 |
|
|
2019
Q3 | $29K | Sell |
260
-53
| -17% | -$5.91K | ﹤0.01% | 122 |
|
|
2019
Q2 | $93K | Sell |
313
-150
| -32% | -$44.6K | 0.01% | 117 |
|
|
2019
Q1 | $208K | Buy |
463
+99
| +27% | +$44.5K | 0.04% | 110 |
|
|
2018
Q4 | $164K | Sell |
364
-7
| -2% | -$3.15K | 0.03% | 110 |
|
|
2018
Q3 | $337K | Buy |
371
+227
| +158% | +$206K | 0.06% | 97 |
|
|
2018
Q2 | $84K | Buy |
144
+61
| +73% | +$35.6K | 0.02% | 116 |
|
|
2018
Q1 | $54K | Buy |
+83
| New | +$54K | 0.01% | 194 |
|